Catalyst Wire Dossier Catalyst Wire Dossier

anti-PCSK9 antibody

· Amgen
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for anti-PCSK9 antibody, covering 2015-12-22 to 2018-08-31. Get the full timeline:

Most recent: Clinical Trial Update: Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects-4 [Phase 3]

See pricing